2024年9月23日 · Macular Telangiectasia Treatment. Over the years, researchers have studied many MacTel treatments. None have proven to significantly improve vision. Since the disease …

This review will discuss the pathophysiology, clinical features, important diagnostic imaging studies and available treatment options for MacTel. Keywords: macular telangiectasia type 2, …

2025年2月18日 · We do know that some patients may only need careful monitoring and may not need treatment. If the blood vessels begin to leak fluid and cause swelling and scarring, …

2024年9月28日 · Macular telangiectasia is an eye disease that leads to a loss of sharp central vision. Learn more about the symptoms, types, treatments, and more.

For neovascular cases, intravitreal anti-VEGF are the mainstay of treatment, although transpupillary therapy and photodynamic therapy have been used in the past. Neuroprotective …

Intravitreal anti-VEGF agents including the Food and Drug Administration approved ranibizumab and nonapproved bevacizumab have been found to be effective in reducing macular edema …

2024年6月6日 · Macular telangiectasia type 2 (MacTel2) is a rare eye condition that causes gradually worsening vision loss in both eyes. It can be detected with diagnostic tests that …

Idiopathic macular telangiectasia type 2 (MacTel) is a rare entity characterized by bilateral telangiectasia and dilation of the retinal capillaries in the juxtafoveal area, located mainly …

2024年6月11日 · MacTel2 is a rare eye disease, with a prevalence of approximately 1 out of every 5,000 to 10,000 people. This condition affects people over age 40. Treatments for MacTel2 …

In Mactel type 1, laser photocoagulation of the telangiectasia remains the mainstay in controlling macular edema, while anti-vascular endothelial growth factor (anti-VEGF) agents provide short …